Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Beta Bionics, Inc. (BBNX : NSDQ)

• Company Description    Beta Bionics Inc. is a commercial-stage medical device company engaged in the design, development and commercialization of solutions. Beta Bionics Inc. is based in IRVINE, Calif. Number of Employees: 423

• Price / Volume Information    Yesterday's Closing Price: $19.33 Daily Weekly Monthly 20 Day Moving Average: 983,614 shares Shares Outstanding: 44.99 (millions) Market Capitalization: $869.65 (millions) Beta: 3.37 52 Week High: $32.71 52 Week Low: $8.80 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 9.70% 10.49% 12 Week 38.57% 35.64% Year To Date -36.56% -43.41%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 11 HUGHES - IRVINE,CA 92618 USA ph: 949-427-7785 fax: - ir@betabionics.com http://www.betabionics.com

• General Corporate Information    Officers Sean Saint - Chief Executive Officer and Director Adam Lezack - Chairperson of the Board of Directors Stephen Feider - Chief Financial Officer Sean Carney - Director Dan Dearen - Director Peer Information Beta Bionics, Inc. (ABMD) Beta Bionics, Inc. (DMDS) Beta Bionics, Inc. (CPWY.) Beta Bionics, Inc. (EQUR) Beta Bionics, Inc. (ECIA) Beta Bionics, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 08659B102 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 10/27/26 Share - Related Items Shares Outstanding: 44.99 Most Recent Split Date: (:1) Beta: 3.37 Market Capitalization: $869.65 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.55 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.10 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 2.07% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 10/27/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.39 Price/Cash Flow: - Price / Sales: 7.31 EPS Growth vs. Year Ago Period: -35.90% vs. Previous Quarter: -8.16% Sales Growth vs. Year Ago Period: 37.76% vs. Previous Quarter: 15.88% ROE 06/30/26 - -26.30 03/31/26 - -23.00 12/31/25 - -20.29 ROA 06/30/26 - -23.25 03/31/26 - -20.55 12/31/25 - -18.32 Current Ratio 06/30/26 - 8.88 03/31/26 - 10.69 12/31/25 - 8.66 Quick Ratio 06/30/26 - 7.96 03/31/26 - 9.67 12/31/25 - 7.96 Operating Margin 06/30/26 - -61.31 03/31/26 - -60.27 12/31/25 - -60.60 Net Margin 06/30/26 - -61.31 03/31/26 - -60.27 12/31/25 - -73.02 Pre-Tax Margin 06/30/26 - -61.31 03/31/26 - -60.27 12/31/25 - -73.02 Book Value 06/30/26 - 5.70 03/31/26 - 6.09 12/31/25 - 6.53 Inventory Turnover 06/30/26 - 2.21 03/31/26 - 2.27 12/31/25 - 2.38 Debt-to-Equity 06/30/26 - 0.00 03/31/26 - 0.00 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - 0.00 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©